Matthew Hamilton Rosenberg’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$897K Buy
748
+98
+15% +$100K 0.17% 63
2026
Q1
$598K Hold
650
0.12% 76
2025
Q4
$699K Buy
650
+9
+1% +$8.61K 0.14% 64
2025
Q3
$489K Sell
641
-25
-4% -$18.6K 0.11% 88
2025
Q2
$519K Buy
666
+24
+4% +$18.6K 0.12% 81
2025
Q1
$530K Sell
642
-50
-7% -$41.6K 0.13% 73
2024
Q4
$534K Buy
692
+18
+3% +$14.9K 0.14% 70
2024
Q3
$597K Buy
674
+20
+3% +$18K 0.16% 67
2024
Q2
$598K Sell
654
-13
-2% -$10.4K 0.18% 61
2024
Q1
$507K Buy
667
+28
+4% +$19.9K 0.15% 70
2023
Q4
$373K Buy
639
+11
+2% +$6.42K 0.11% 93
2023
Q3
$337K Hold
628
0.11% 94
2023
Q2
$295K Sell
628
-165
-21% -$69.2K 0.1% 114
2023
Q1
$272K Hold
793
0.09% 140
2022
Q4
$290K Hold
793
0.1% 133
2022
Q3
$256K Buy
793
+9
+1% +$2.85K 0.1% 121
2022
Q2
$255K Hold
784
0.1% 127
2022
Q1
$225K Buy
784
+44
+6% +$11.3K 0.08% 168
2021
Q4
$204K Hold
740
0.07% 179
2021
Q3
$171K Buy
740
+188
+34% +$46.4K 0.07% 188
2021
Q2
$127K Hold
552
0.07% 219
2021
Q1
$103K Buy
552
+49
+10% +$9.59K 0.06% 244
2020
Q4
$85K Buy
503
+70
+16% +$10.5K 0.05% 250
2020
Q3
$64K Hold
433
0.05% 272
2020
Q2
$71K Buy
433
+90
+26% +$13.8K 0.06% 250
2020
Q1
$48K Buy
+343
New +$47.1K 0.05% 261

Other funds holding LLY

Matthew Hamilton Rosenberg's LLY Position: Q2 2026 in Review

Matthew Hamilton Rosenberg increased its Eli Lilly (LLY) stake by 15% in Q2 2026, buying an estimated $100K and bringing the position to 748 shares worth $897K. The position accounts for 0.17% of the portfolio, ranked #63.

Matthew Hamilton Rosenberg first reported a position in LLY in Q1 2020 and has held it in 26 quarters since. 4,601 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Matthew Hamilton Rosenberg held 748 shares of Eli Lilly worth $897K as of Q2 2026.
  • Matthew Hamilton Rosenberg bought 98 Eli Lilly shares in Q2 2026, an estimated $100K.
  • Eli Lilly made up 0.17% of Matthew Hamilton Rosenberg's portfolio in Q2 2026, its #63 holding.
  • Matthew Hamilton Rosenberg first reported a position in Eli Lilly in Q1 2020 and has held it in 26 quarters since.
  • 4,601 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Matthew Hamilton Rosenberg's 13F filing for Q2 2026, filed 17 Jul 2026.